Page 81 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

60 PART I The Biology and Pathogenesis of Cancer

adjunctive treatment for oral malignant melanoma in dogs follow- 205. Folkman J: Tumor angiogenesis and tissue factor, Nat Med 2:167–
ing surgical excision of the primary tumor, Am J Vet Res 72:1631– 168, 1996.
1638, 2011. 206. Folkman J: Angiogenesis: an organizing principle for drug discov-
VetBooks.ir 187. Bagge U, Skolnik G, Ericson LE: The arrest of circulating tumor 207. Kerbel RS: Tumor angiogenesis: past, present and the near future,
ery? Nat Rev Drug Discov 6:273–286, 2007.
cells in the liver microcirculation. A vital fluorescence microscopic,
electron microscopic and isotope study in the rat, J Cancer Res Clin
Carcinogenesis 21:505–515, 2000.
Oncol 105:134–140, 1983. 208. Nagy JA, Chang SH, Shih SC, et al.: Heterogeneity of the tumor
188. Chambers AF, MacDonald IC, Schmidt EE, et al.: Steps in tumor vasculature, Semin Thromb Hemost 36:321–331, 2010.
metastasis: new concepts from intravital videomicroscopy, Cancer 209. Olive KP, Jacobetz MA, Davidson CJ, et al.: Inhibition of Hedge-
Metastasis Rev 14:279–301, 1995. hog signaling enhances delivery of chemotherapy in a mouse model
189. Chambers AF, Naumov GN, Varghese HJ, et al.: Critical steps of pancreatic cancer, Science 324:1457–1461, 2009.
in hematogenous metastasis: an overview, Surg Oncol Clin N Am 210. Pircher A, Hilbe W, Heidegger I, et al.: Biomarkers in tumor angio-
10:243–255, 2001. genesis and anti-angiogenic therapy, Int J Mol Sci 12:7077–7099,
190. Kienast Y, von Baumgarten L, Fuhrmann M, et al.: Real-time 2011.
imaging reveals the single steps of brain metastasis formation, Nat 211. Boss KM, Muradyan N, Thrall DE: DCE-MRI: a review and appli-
Med 16:116–122, 2010. cations in veterinary oncology, Vet Comp Oncol 11:87–100, 2013.
191. Li DM, Feng YM: Signaling mechanism of cell adhesion molecules 212. Fidler IJ, Kripke ML: Metastasis results from preexisting variant
in breast cancer metastasis: potential therapeutic targets, Breast cells within a malignant tumor, Science 197:893–895, 1977.
Cancer Res Treat 128:7–21, 2011. 213. Fidler IJ: The pathogenesis of cancer metastasis: the ‘seed and soil’
192. Zigler M, Kamiya T, Brantley EC, et al.: PAR-1 and thrombin: hypothesis revisited, Nat Rev Cancer 3:453–458, 2003.
the ties that bind the microenvironment to melanoma metastasis, 214. Hunter K, Welch DR, Liu ET: Genetic background is an important
Cancer Res 71:6561–6566, 2011. determinant of metastatic potential, Nat Genet 34:23–24, 2003.
193. Villares GJ, Zigler M, Bar-Eli M: The emerging role of the throm- 215. Hunter KW: Allelic diversity in the host genetic background may
bin receptor (PAR-1) in melanoma metastasis–a possible therapeu- be an important determinant in tumor metastatic dissemination,
tic target, Oncotarget 2:8–17, 2011. Cancer Lett 200:97–105, 2003.
194. Groom AC, MacDonald IC, Schmidt EE, et al.: Tumour metastasis 216. Hunter KW: Host genetics and tumour metastasis, Br J Cancer
to the liver, and the roles of proteinases and adhesion molecules: 90:752–755, 2004.
new concepts from in vivo videomicroscopy, Can J Gastroenterol 217. Khanna C, Hunter K: Modeling metastasis in vivo, Carcinogenesis
13:733–743, 1999. 26:513–523, 2005.
195. Chambers AF: The metastatic process: basic research and clinical 218. Luzzi KJ, MacDonald IC, Schmiedt EE, et al.: Multistep nature of
implications, Oncol Res 11:161–168, 1999. metastatic inefficiency: dormancy of solitary cells after successful
196. Liu Q, Zhang H, Jiang X, et al.: Factors involved in cancer metasta- extravasation and limited survival of early micrometastases, Am J
sis: a better understanding to “seed and soil” hypothesis, Mol Can- Pathol 153:865–873, 1998.
cer 16:176, 2017. 219. Loberg RD, Fridman Y, Pienta BA, et al.: Detection and isolation
197. Martin TA, Harrison G, Mansel RE, et al.: The role of the CD44/ of circulating tumor cells in urologic cancers: a review, Neoplasia
ezrin complex in cancer metastasis, Crit Rev Oncol Hematol 6:302–309, 2004.
46:165–186, 2003. 220. Butler TP, Gullino PM: Quantitation of cell shedding into efferent
198. Balkwill F: Chemokine biology in cancer, Semin Immunol 15:49– blood of mammary adenocarcinoma, Cancer Res 35:512–516, 1975.
55, 2003. 221. Psaila B, Lyden D: The metastatic niche: adapting the foreign soil,
199. Kaplan RN, Rafii S, Lyden D: Preparing the “soil”: the premeta- Nat Rev Cancer 9:285–293, 2009.
static niche, Cancer Res 66:11089–11093, 2006. 222. Chambers AF, Naumov GN, Vantyghem SA, et al.: Molecular biol-
200. Kaplan RN, Riba RD, Zacharoulis S, et al.: VEGFR1-positive hae- ogy of breast cancer metastasis. Clinical implications of experimen-
matopoietic bone marrow progenitors initiate the pre-metastatic tal studies on metastatic inefficiency, Breast Cancer Res 2:400–407,
niche, Nature 438:820–827, 2005. 2000.
201. Al-Mehdi AB, Tozawa K, Fisher AB, et al.: Intravascular origin of 223. Paez D, Labonte MJ, Bohanes P, et al.: Cancer dormancy: a model
metastasis from the proliferation of endothelium-attached tumor of early dissemination and late cancer recurrence, Clin Cancer Res
cells: a new model for metastasis, Nat Med 6:100–102, 2000. 18:645–653, 2012.
202. Cooper CR, Chay CH, Gendermalik JD, et al.: Stromal factors 224. Barkan D, Kleinman H, Simmons JL, et al.: Inhibition of meta-
involved in prostate carcinoma metastasis to bone, Cancer 97 static outgrowth from single dormant tumor cells by targeting the
(Suppl 3):739–747, 2003. cytoskeleton, Cancer Res 68:6241–6250, 2008.
203. De Wever O, Mareel M: Role of tissue stroma in cancer cell inva- 225. Barkan D, El Touny LH, Michalowski AM, et al.: Metastatic
sion, J Pathol 200:429–447, 2003. growth from dormant cells induced by a col-I-enriched fibrotic
204. Engels B, Rowley DA, Schreiber H: Targeting stroma to treat can- environment, Cancer Res 70:5706–5716, 2010.
cers, Semin Cancer Biol 22:41–49, 2011.